Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J. Wright, Izabella Zamora, Milan Parikh, Deepika Yeramosu et autres
0 citationsNature Communications
Russell W. Jenkins
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
263Publications signalées
11574Citations signalées
7Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesSphingolipid Metabolism and SignalingImmune cells in cancer
Publications récentes
Figure S4 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S5 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S3 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S11 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S10 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S7 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S2 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S1 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S6 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S9 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
Figure S8 from TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.